Investor profile
Eli lilly and company has backed 6 European tech companies across 7 funding rounds between 2023 and 2025, joining rounds totalling €226M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Maxion Therapeutics | UK | 1 | €66M |
| haya therapeutics | Switzerland | 1 | €58M |
| Trimtech Therapeutics | UK | 1 | €29M |
| DiogenX | France | 1 | €28M |
| Laverock Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Maxion Therapeutics | Series A | €66M | 2025-03 |
| haya therapeutics | Series A | €58M | 2025-05 |
| Trimtech Therapeutics | Seed | €29M | 2025-03 |
| DiogenX |
| 2 |
| €23M |
| ViaNautis | UK | 1 | €23M |
| Series A |
| €28M |
| 2023-05 |
| ViaNautis | Series A | €23M | 2023-11 |
| Laverock Therapeutics | Seed | €16M | 2023-10 |
| Laverock Therapeutics | Seed | €7.6M | 2025-06 |
